Usana Health Sciences (USNA) Asset Writedowns and Impairment (2010 - 2026)

Usana Health Sciences (USNA) has 5 years of Asset Writedowns and Impairment data on file, last reported at $1.3 million in Q2 2026.

• Asset Writedowns and Impairment for Q2 2026 came in at $1.3 million, up 7.27% year-over-year; the trailing twelve-month figure through Apr 2026 was $2.8 million (up 898.92% YoY), and the FY2026 annual result was $2.7 million, changed N/A from the prior year.
• Asset Writedowns and Impairment climbed to $1.3 million in Q2 2026 per USNA's latest filing, from $264000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $2.3 million in Q2 2023 and troughed at -$1.9 million in Q4 2024.
• A 4-year average of $506076.9 and a median of $423000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2024 and 2026: Asset Writedowns and Impairment slumped 273.32% in 2024, then jumped 113.98% in 2026.
• A 4-year view of Asset Writedowns and Impairment shows it stood at -$506000.0 in 2023, then tumbled by 273.32% to -$1.9 million in 2024, then soared by 119.59% to $370000.0 in 2025, then jumped by 251.08% to $1.3 million in 2026.
• Business Quant data shows USNA's Asset Writedowns and Impairment at $1.3 million in Q2 2026, $264000.0 in Q1 2026, and $370000.0 in Q3 2025.